STOCK TITAN

Zynex, Inc Sets Third Quarter 2023 Earnings Call

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Zynex, Inc. to hold conference call on October 26, 2023 to discuss Q3 financial results.
Positive
  • Zynex, Inc. will discuss its financial results for Q3 2023 in a conference call on October 26, 2023 at 4:15 PM Eastern Time.
Negative
  • None.

ENGLEWOOD, Colo., Oct. 12, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Thursday, October 26, 2023 at 4:15 PM Eastern Time to discuss its financial results for the third quarter ended September 30, 2023.  Financial results will be issued in a press release prior to the call.

Zynex management will host the conference call, followed by a question and answer session.

Date: Thursday, October 26, 2023
Time: 4:15 PM Eastern Time (1:15 PM Pacific Time)
U.S. dial-in number: 844-825-9790
Canada dial-in number: 855-669-9657
International number: 412-317-5170
Webcast: Q3 2023 Webcast Link

The Company will also provide a link at https://zynexmed.investorroom.com/ for those who wish to stream the call via webcast. Please call the conference telephone number 5-10 minutes prior to the start time.

About Zynex, Inc.

 Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com.

Investor Relations Contact:
Quinn Callanan, CFA or Brian Prenoveau, CFA
MZ Group – MZ North America
ZYXI@mzgroup.us
+949 694 9594

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/zynex-inc-sets-third-quarter-2023-earnings-call-301954755.html

SOURCE Zynex

Zynex, Inc. will hold the conference call on Thursday, October 26, 2023 at 4:15 PM Eastern Time.

You can stream the conference call via webcast at https://zynexmed.investorroom.com/.

The U.S. dial-in number is 844-825-9790, the Canada dial-in number is 855-669-9657, and the international number is 412-317-5170.

The financial results will be issued in a press release prior to the call.
ZYNEX INC

NASDAQ:ZYXI

ZYXI Rankings

ZYXI Latest News

ZYXI Stock Data

365.59M
15.72M
51.14%
31.25%
18%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
ENGLEWOOD

About ZYXI

zynex, inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. zynex medical is a provider of electrotherapy products for home use. zynex monitoring solutions develops products for cardiac monitoring for use in hospitals. zynex neurodiagnostics develops devices for emg and eeg diagnostic applications within neurology disciplines. zynex medical's product line is fully developed, fda/ce cleared, commercially sold, and has been developed to uphold the company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. zynex monitoring solutions and zynex neurodiagnostics are currently both in the development stages without any significant revenues.